PT-141 10mg

Comprehensive Guide to PT-141 10mg (Bremelanotide): Melanocortin Receptor Agonist Structure, Neuromodulatory Research Standards, and Analytical Purity

Welcome to Suzhou Lanhai Peptide, your trusted global source for advanced synthetic peptides, amino acid derivatives, and specialized laboratory storage solutions. In modern neuroendocrinology research, melanocortin pathway studies, and advanced pharmaceutical formulation research, investigating targeted cyclic peptide analogues requires absolute precision, verifiable purity, and strict compliance with research standards. When exploring central nervous system receptor activation, autonomic signaling, and melanocortin receptor subtype specificity, utilizing high-purity PT-141 10mg (Bremelanotide) is vital for achieving reproducible scientific outcomes.

This comprehensive guide explores the structural sequence, biochemical properties, analytical verification standards, and proper laboratory storage protocols for PT-141 10mg. By examining real-world industry benchmarks and analytical chemistry standards, we outline why optimized sourcing and handling are fundamental to advanced neurobiological and endocrine research.

1. Understanding PT-141: Structure, Mechanism, and Research Scope

PT-141, commonly known as Bremelanotide, is a synthetic cyclic heptapeptide derivative of the melanocortin peptide hormone $\alpha$-melanocyte-stimulating hormone ($\alpha$-MSH). Its specific cyclic structure (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH) is engineered with a lactam bridge connecting the aspartic acid and lysine residues, which confers enhanced metabolic stability and receptor binding affinity.

The Mechanism of Action in Biomedical Research

In contemporary biochemical and pharmacological investigations, PT-141 is examined for several key cellular pathways:

• Melanocortin Receptor Agonism: Unlike earlier analogues that targeted peripheral tanning pathways, PT-141 acts primarily as an agonist at central melanocortin receptors, specifically MC3R and MC4R, located within the hypothalamus and limbic system.

• Central Autonomic and Behavioral Signaling: Research demonstrates that activation of central MC4R pathways modulates descending autonomic signaling circuits, influencing physiological arousal, metabolic homeostasis, and dopaminergic neurotransmission without relying on vascular nitric oxide pathways.

• Energy Balance and Inflammatory Studies: In vitro and animal model research evaluates its broader role in regulating feeding behavior, systemic energy expenditure, and modulating acute inflammatory cascades.

2. Analytical Verification and High-Purity Synthesis Standards

For institutional buyers, academic researchers, and biotechnology procurement managers, batch verification is paramount. Cyclic lactam-bridged peptides require rigorous solid-phase peptide synthesis (SPPS), controlled cyclization protocols, and HPLC purification to ensure proper intramolecular ring closure and structural integrity.

High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)

Every batch of PT-141 10mg distributed by Suzhou Lanhai Peptide undergoes rigorous verification via HPLC and MS to guarantee purity levels exceeding 98% to 99%+, ensuring minimal uncyclized linear precursors, dimers, or synthesis impurities.

Technical Specification Comparison

3. Laboratory Handling, Reconstitution, and Storage Protocols

Synthetic cyclic peptides like PT-141 are supplied as stabilized, vacuum-freeze-dried (lyophilized) powders to maximize shelf-life stability. Proper laboratory handling is essential to preserve peptide integrity upon reconstitution.

Reconstitution Best Practices

• Solvent Selection: Reconstitute lyophilized PT-141 10mg using sterile bacteriostatic water for injection or analytical buffer solutions in a clean laminar flow hood.

• Avoiding Shear Stress: Introduce solvents gently down the inside wall of the vial rather than forcefully spraying liquid directly onto the lyophilized cake to prevent peptide bond shearing.

Cold-Chain Storage Guidelines

• Dry Powder Storage: Store sealed vials of lyophilized PT-141 at $-20^\circ C$ desiccated away from light and moisture.

• Reconstituted Storage: Once reconstituted, solutions should be kept between $2^\circ C$ and $8^\circ C$ protected from light and utilized within short-term experimental windows to prevent enzymatic degradation or oxidation of tryptophan residues.

4. Mandatory Research Disclaimer and Compliance

• For Laboratory and Research Use Only: All peptide products offered by Suzhou Lanhai Peptide, including PT-141 10mg, are strictly intended for in vitro laboratory research, analytical testing, and scientific study. They are not approved for human consumption, clinical trials on humans, veterinary use, or therapeutic self-administration.

5. Frequently Asked Questions (FAQs)

1. What is the structural difference between PT-141 and standard melanocortin analogs?

PT-141 (Bremelanotide) is a cyclic heptapeptide featuring a lactam bridge between its aspartic acid and lysine residues, which enhances metabolic stability and increases binding selectivity for MC3R and MC4R receptors.

2. What purity level does Suzhou Lanhai Peptide guarantee for PT-141 10mg?

Every batch of PT-141 10mg is backed by analytical documentation confirming an HPLC purity rating of 98% to 99% or higher.

3. How should lyophilized PT-141 10mg be stored prior to reconstitution?

Vials of dry powder should be stored tightly sealed in a dry environment at $-20^\circ C$ protected from light to maintain structural stability.

4. Are Certificates of Analysis (COAs) provided with orders?

Yes. Every order includes or provides access to batch-specific HPLC and Mass Spectrometry reports to verify purity and molecular weight for institutional compliance.

5. Can PT-141 be used in human clinical applications?

No. All products sold by Suzhou Lanhai Peptide are restricted strictly to laboratory research and development use only and are prohibited from human or clinical application.